Cost–utility analysis of vaccination against HPV in Israel

This publication has 47 references indexed in Scilit:

• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
  British Journal of Cancer, 2006
• Chapter 13: Current findings from prophylactic HPV vaccine trials
  Vaccine, 2006
• Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
  PLoS Medicine, 2006
• Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK
  Current Medical Research and Opinion, 2006
• Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine
  Vaccine, 2005
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective
  International Journal of Cancer, 2004
• Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
  The Lancet, 2003
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
  British Journal of Cancer, 2003
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
  JNCI Journal of the National Cancer Institute, 1995